Role of hepatitis B antibody in predicting reactivation of resolved hepatitis B virus infection in leukemia patients
- 27 March 2020
- journal article
- research article
- Published by Elsevier BV in Antiviral Research
- Vol. 177, 104765
- https://doi.org/10.1016/j.antiviral.2020.104765
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81670530)
- Start-up foundation (2018QDL035)
- Hangzhou Normal University
This publication has 38 references indexed in Scilit:
- American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug TherapyGastroenterology, 2015
- Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infectionClinical Microbiology & Infection, 2014
- Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcomeClinical Microbiology & Infection, 2014
- The global burden of liver disease: The major impact of ChinaJournal of Hepatology, 2014
- Novel Therapeutics in Acute Myeloid LeukemiaCurrent Hematologic Malignancy Reports, 2014
- New drugs for aggressive B-cell and T-cell lymphomasThe Lancet Oncology, 2010
- Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignanciesHematology, 2010
- Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without RituximabJournal of Clinical Oncology, 2009
- A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trialJournal of Hepatology, 2007
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyGastroenterology, 2004